Creatio has international recognition in the area of Advanced Therapies

The research group of Dr. Canals, together with Creatio’s associated groups, form a team of experts in regenerative medicine who develop in vitro and in vivo models using a wide variety of murine models and animal and human cell lines.

The common goal of the different groups is to understand the molecular mechanisms of neurodevelopment in order to find better treatments for currently incurable neurodegenerative diseases, such as Parkinson’s disease, Huntington’s disease or ischemia.